John Blaine Mowery Jr, MD | |
420 S 5th Ave, West Reading, PA 19611-2143 | |
(484) 628-8000 | |
Not Available |
Full Name | John Blaine Mowery Jr |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 420 S 5th Ave, West Reading, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285202218 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MT222743 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
John Blaine Mowery Jr, MD Po Box 13579, Reading, PA 19612-3579 Ph: () - | John Blaine Mowery Jr, MD 420 S 5th Ave, West Reading, PA 19611-2143 Ph: (484) 628-8000 |
News Archive
Silence Therapeutics plc announces that the Company is executing a strategic plan designed to optimally organize its resources following its recent merger with Intradigm Corporation. Moving forward, all research activities related to Silence's novel RNA interference (RNAi) therapeutic platforms, including technologies that have emerged from both Silence and Intradigm, will take place at the Company's Berlin location.
Today, Merck announced that it has significantly expanded the number of Merck medicines available through its Merck Helps patient assistance programs, which include the Merck Patient Assistance Program, the Merck Vaccine Patient Assistance Program, the ACT Program for Oncology and Hepatitis C medicines, and the SUPPORT Program for HIV/AIDS medicines.
In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias.
Baxter International Inc. today announced topline results from a Phase 3 clinical trial evaluating the safety, efficacy and pharmacokinetics (PK) of BAX 111. BAX 111 is a recombinant von Willebrand factor (rVWF) under investigation for the treatment of bleeding episodes in patients with von Willebrand disease, the most common type of inherited bleeding disorder.
› Verified 8 days ago
Liza Gergenti, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-3528 | |
Joshua Adam Werner, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-3637 | |
Eric Smith, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
James Sullivan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
Ray Morganti, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6th Ave & Spruce St, West Reading, PA 19611 Phone: 610-988-8218 | |
Dr. Joseph Patrick Corcoran Iv, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
Memu-iye Kamara, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 |